Caricamento...
BORA-dependent PLK1 regulation: A new weapon for cancer therapy?
The mitotic kinase polo like kinase 1 (PLK1) is overexpressed in many cancers and its inhibition slows down proliferation and increases apoptosis in cancer cell lines. Understanding how PLK1 is activated is therefore crucial for the development of novel PLK1 inhibitors with anticancer properties. We...
Salvato in:
| Pubblicato in: | Mol Cell Oncol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5068183/ https://ncbi.nlm.nih.gov/pubmed/27857970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2016.1199265 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|